PharmaBoardroom

New IQVIA Study Sparks Controversy in Moroccan Pharma

Ensuring the country’s “sanitary sovereignty” has long been a key policy for Morocco and its government. In order to encourage the local…

Brecht Vanneste – Associate VP & Managing Director,…

Brecht Vanneste, associate VP and managing director of MSD in Belgium and Luxembourg, highlights the strategic significance of the affiliate as an…

Juan de Villafranca – Executive Director, AMELAF, Mexico

Juan de Villafranca, executive director of the Asociacion Mexicana de Laboratorios Farmaceuticos (AMELAF), shares the exciting new initiatives he has…

Belgian Manufacturing’s Continuing Appeal for Global Innovative…

Over the past few decades, pharma multinationals have been increasingly drawn to the highly cost-competitive markets of Central Eastern Europe (CEE)…

Worldwide Demand for Protective Masks Booms Amid Coronavirus…

The 2019 Wuhan coronavirus outbreak has seen a surge in demand for protective masks as publics across the world seek to protect themselves from…

Jiří Žák – Chairman, FARMAK, Czech Republic

In 1996, Jiří Žák, chairman & current CEO of FARMAK, took over the state-owned producer of vitamins FARMAKON where he previously worked for 30…

UCB’s Latest Investment in Belgian Biopharma Manufacturing

After reaching revenues of EUR 2.323 billion in the first six months of 2019, UCB announced on December 18 that it will build an innovative…

Biocon’s New Facility & Expansion in APAC

Biocon, the first Indian company to have a biosimilar drug approved in the US, is taking another step forward with a new manufacturing facility and an…